| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.095 | 0.09 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.095 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |